Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
TherapeuticsMD, Inc. | Chief Executive Officer | Common Stock | 62.6K | $140K | $2.24 | Dec 7, 2023 | Direct |
TherapeuticsMD, Inc. | Chief Executive Officer | Restricted Stock Units | 0 | $3.64 | Dec 5, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
TXMD | TherapeuticsMD, Inc. | Dec 5, 2023 | 4 | -$43.7K | 4 | Dec 7, 2023 | Chief Executive Officer |
TXMD | TherapeuticsMD, Inc. | Apr 12, 2023 | 5 | -$2.52K | 4/A | May 4, 2023 | Chief Executive Officer |
TXMD | TherapeuticsMD, Inc. | Feb 21, 2023 | 1 | $0 | 4 | Feb 23, 2023 | Chief Executive Officer |
TXMD | TherapeuticsMD, Inc. | Dec 31, 2022 | 1 | $0 | 5 | Feb 13, 2023 | Chief Executive Officer |
TXMD | TherapeuticsMD, Inc. | Dec 6, 2022 | 7 | -$5.18K | 4 | Dec 9, 2022 | General Counsel |
TXMD | TherapeuticsMD, Inc. | Mar 31, 2022 | 1 | $0 | 4 | Mar 31, 2022 | General Counsel |
TXMD | TherapeuticsMD, Inc. | Mar 23, 2022 | 1 | $0 | 4 | Mar 28, 2022 | General Counsel |
TXMD | TherapeuticsMD, Inc. | Mar 23, 2022 | 1 | $0 | 4 | Mar 28, 2022 | General Counsel |
TXMD | TherapeuticsMD, Inc. | Mar 14, 2022 | 2 | $0 | 4 | Mar 15, 2022 | General Counsel |
TXMD | TherapeuticsMD, Inc. | Sep 29, 2021 | 5 | $0 | 4 | Oct 1, 2021 | General Counsel |
TXMD | TherapeuticsMD, Inc. | Jul 1, 2021 | 2 | $0 | 4 | Jul 2, 2021 | General Counsel |
TXMD | TherapeuticsMD, Inc. | May 10, 2021 | 3 | -$22.5K | 4 | May 12, 2021 | General Counsel |